Literature DB >> 21271027

[CBO/ALCON teaching method of phacoemulsification: results of Hospital de Olhos do Paraná].

Ana Flávia de Castro Fischer1, Eduardo Machado Estevão Pires, Fernando Klein, Otávio Siqueira Bisneto, Eduardo Sone Soriano, Hamilton Moreira.   

Abstract

PURPOSE: To analyze the results obtained with a new phacoemulsification teaching method in the specialization course of Hospital de Olhos do Paraná.
METHODS: A retrospective study evaluated the results of a "reversal" method used in the CBO/ALCON teaching program at the Hospital de Olhos do Paraná. The method is based on the student progression through five checkpoints starting from the end of the surgery towards the beginning and analysis of intra- and postoperative complications at each one of the checkpoints.
RESULTS: Of 84 operated eyes, 77 (91.67%) presented final visual acuity of 20/40 or better. Among the complications, the main one was the posterior capsular rupture and occurred in 11 (13.09%) of 13 (15.48%) eyes with complications.
CONCLUSION: The "reversal" teaching method used in the CBO/ALCON teaching program is appropriate to the student, his instructor, as well as to the patient.

Entities:  

Mesh:

Year:  2010        PMID: 21271027     DOI: 10.1590/s0004-27492010000600010

Source DB:  PubMed          Journal:  Arq Bras Oftalmol        ISSN: 0004-2749            Impact factor:   0.872


  2 in total

1.  Comparison of the Posterior Capsule Rupture Rates Associated with Conventional (Start to Finish) Versus Reverse Methods of Teaching Phacoemulsification.

Authors:  Milind Suryawanshi; Parikshit Gogate; Anil N Kulkarni; Archana Biradar; Pooja Bhomaj
Journal:  Middle East Afr J Ophthalmol       Date:  2016 Apr-Jun

2.  Impact of virtual reality simulation on learning barriers of phacoemulsification perceived by residents.

Authors:  Danny Siu-Chun Ng; Zihan Sun; Alvin Lerrmann Young; Simon Tak-Chuen Ko; Jerry Ka-Hing Lok; Timothy Yuk-Yau Lai; Shameema Sikder; Clement C Tham
Journal:  Clin Ophthalmol       Date:  2018-05-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.